Addo S, Lycan T, Soto-Pantoja DR, Tsai YT, et al. Randomized phase 2 trial of pembrolizumab alone or in combination with low dose chemotherapy for patients with non-small cell lung cancer and poor performance status. Lung Cancer 2025;203:108513.
PMID: 40203764